Quantcast

Latest AbbVie Inc. Stories

2014-10-20 20:26:42

- Will announce third-quarter 2014 financial results on Oct. 31, 2014 - NORTH CHICAGO, Ill., Oct. 20, 2014 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today authorized a new $5 billion stock repurchase program and increased the company's quarterly cash dividend by nearly 17 percent. The authorization allows for the repurchase of up to $5 billion of the company's common stock, which is expected to be executed over the next several years. The stock repurchase...

2014-10-20 16:27:36

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION NORTH CHICAGO, Ill., Oct. 20, 2014 /PRNewswire/ -- AbbVie Inc. ("AbbVie") and Shire plc ("Shire") have agreed to terminate their proposed merger following the decision by AbbVie's Board to withdraw support for the proposed transaction. The Company's decision was based...

2014-10-16 00:21:26

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION NORTH CHICAGO, Ill., Oct. 15, 2014 /PRNewswire/ -- Following Shire plc's ("Shire") waiver of the three-day notice period, AbbVie Inc. ("AbbVie") (NYSE: ABBV) announces today its Board of Directors' withdraws its recommendation made on July 18, 2014 regarding the proposed...

2014-10-15 04:22:07

DUBLIN, October 15, 2014 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION The Board of Shire plc (LSE: SHP, NASDAQ: SHPG) notes the announcement by AbbVie Inc. ("AbbVie") of its Board's intention to reconsider its recommendation of the offer for Shire. Shire confirms...

2014-10-14 20:23:23

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION NORTH CHICAGO, Ill., Oct. 14, 2014 /PRNewswire/ -- AbbVie Inc. ("AbbVie") announces it has notified Shire plc ("Shire") of its Board of Directors' intention to reconsider the recommendation made on July 18, 2014 that AbbVie stockholders adopt the merger...

2014-10-02 12:32:17

DUBLIN, Oct. 2, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Hypercholesterolemia Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Hypercholesterolemia is defined as a condition characterized by abnormally high levels of total cholesterol and LDL cholesterol in the blood. High cholesterol levels, in turn, can lead to cardiovascular diseases such as atherosclerosis and stroke. The normal physiological range...

2014-09-25 08:27:02

-- HUMIRA is now indicated to treat pediatric patients 6 years of age and older with moderately to severely active Crohn's disease who have had an inadequate response to corticosteroids or immunomodulators such as azathioprine, 6-mercaptopurine, or methotrexate NORTH CHICAGO, Ill., Sept. 25, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today that the U.S. Food and Drug Administration (FDA) has approved HUMIRA(®) (adalimumab) for reducing signs and symptoms, and achieving and...

2014-09-19 16:24:13

NORTH CHICAGO, Ill., Sept. 19, 2014 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.42 per share. The cash dividend is payable Nov. 17, 2014 to stockholders of record at the close of business on Oct. 15, 2014. About AbbVieAbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to...

2014-09-15 08:25:17

NEW YORK, Sept. 15, 2014 /PRNewswire/ -- Hynes Keller & Hernandez, LLC is investigating potential claims involving World Acceptance Corp., PTC, Inc. and AbbVie Inc., as detailed below. World Acceptance Corp. ("WRLD") Hynes Keller & Hernandez, LLC is investigating potential claims against the Board of Directors at WRLD (NASDAQGS: WRLD) concerning possible breaches of fiduciary duty related to the Company's alleged issuance of false and misleading statements about its business...

2014-09-08 12:29:59

Commission Alleges That AbbVie Inc. and Besins Healthcare Inc. Filed Sham Lawsuits; AbbVie and Teva Pharmaceuticals USA, Inc. Entered Anticompetitive Agreement to Delay Generic Entry WASHINGTON, Sept. 8, 2014 /PRNewswire-USNewswire/ -- In its latest action to ensure competition in the nation's healthcare markets, the Federal Trade Commission has filed a complaint in federal district court charging several major pharmaceutical companies with illegally blocking American consumers' access to...


Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related